Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.29
+0.06 (0.96%)
At close: Jun 26, 2026, 4:00 PM EDT
6.34
+0.05 (0.79%)
After-hours: Jun 26, 2026, 5:08 PM EDT
Gyre Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Gyre Therapeutics stock have an average target of 19, with a low estimate of 18 and a high estimate of 20. The average target predicts an increase of 202.07% from the current stock price of 6.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2026.
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Noble Financial | Noble Financial | Buy Reiterates $20 | Buy | Reiterates | $20 | +217.97% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +186.17% | May 7, 2026 |
Financial Forecast
Revenue This Year
102.30M
from 116.59M
Decreased by -12.26%
Revenue Next Year
130.75M
from 102.30M
Increased by 27.81%
EPS This Year
-0.02
from 0.18
EPS Next Year
0.06
from -0.02
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 106.0M | 156.4M | |
| Avg | 102.3M | 130.8M | |
| Low | 98.9M | 105.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -9.1% | 52.9% | |
| Avg | -12.3% | 27.8% | |
| Low | -15.2% | 2.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.02 | 0.06 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.